RACHEL CASE: Open Payments
NPI 1104011592 · GREENWOOD, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,120 in 56 payments from 18 companies in 2025. Trend: 2023 $1,607 · 2024 $1,399 · 2025 $1,120
Food & beverage: $1,120
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 11 | $202 |
| Philips North America LLC | 4 | $108 |
| Merck Sharp & Dohme LLC | 5 | $97 |
| E.R. Squibb & Sons, L.L.C. | 6 | $91 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $86 |
| Abbott Laboratories | 3 | $67 |
| Amgen Inc. | 2 | $59 |
| PFIZER INC. | 3 | $56 |
| Novo Nordisk Inc | 2 | $54 |
| Impulse Dynamics (USA) Inc. | 3 | $49 |
Products named: LEQVIO, Ambulatory Monitoring & Diagnostics Undivided, JARDIANCE, VERQUVO, REPATHA, VYNDAQEL, Wegovy, Optimizer.
Industry payments across SC — which companies pay providers there.
